<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">Esophageal reflux</z:e> is common in the Western world and can lead to a number of diseases, such as <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Barrett's predisposes to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and endoscopic surveillance may lead to earlier detection of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>However, clinical methods only identify one patient in 15 with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to find factors that may help identify patients with Barrett's earlier </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Blood samples and detailed histories were taken from 456 patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> who were recruited into three study groups: <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and Barrett's with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>PCR was used to determine the frequency of five functional cytokine polymorphisms: interleukin-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> position +2018 (IL-1 Ra +2018), interleukin-1 beta position -511 (IL-1 beta-511), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha position -238 (TNF-alpha-238), interleukin-10 position +1082 (IL-10 +1082), and interleukin-4 receptor position -1902 (IL-4R -1902) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: IL-1 Ra +2018 genotype 2/2 was associated with Barrett's more commonly than <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (OR-3.7, p= 0.0345) </plain></SENT>
<SENT sid="7" pm="."><plain>The IL-10 +1082 genotype 2/2 was more strongly associated with Barrett's and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> than <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (OR-1.76, p= 0.056 and OR 1.96, p= 0.025, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>There were no differences for the IL-1 beta-511, IL-4R -1902, and TNF-alpha-238 polymorphisms </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Cytokine polymorphisms are more commonly found in patients with Barrett's or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> than those with <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Together with demographic data, this may help identify those patients with Barrett's who would benefit from surveillance </plain></SENT>
</text></document>